H1- antihistamines and activated blood platelets

Inflammation Research

Volumn 55, Issue SUPPL. 1, 2006, Pages

  Petrikova M ^a   Jancinova V ^a   Nosal R ^a   Majekova M ^a   Holomanova D ^b  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b National Transfusion Service   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

DITHIADEN; EMBRAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; LORATADINE;

BINDING AFFINITY; CONFERENCE PAPER; DIPOLE; HUMAN; MALE; NORMAL HUMAN; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

BENZOTHIEPINS; DIPHENHYDRAMINE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; MALE; PLATELET ACTIVATION; PLATELET AGGREGATION;

EID: 33646773915     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-005-0038-9     Document Type: Conference Paper

References (8)

1. Jančinová V, Nosál R, Drábiková K, Danihelová E. On the effect of the antihistaminic drug bromadryl on human platelets in vitro. Inflamm Res 1996; 45: S21-2.
2. 1-histamine antagonist dithiaden inhibits human platelet function in vitro. Platelets 1997; 8: 175-80.
3. 1-receptor effects of antihistamines. Clin Exp Allergy 1999; 29: 39-48.
4. 1-antagonist dithiaden in human PMN leukocytes. Free Rad Res 2002; 36: 975-80.
5. 2). Thromb Res 2002; 105: 339-45.
6. Jančinová V, Nosál R, Drábiková K, Danihelová E. Cooperation of chloroquine and blood platelets in inhibition of polymorphonuclear leukocyte chemiluminescence. Biochem Pharmacol 2001; 62: 1629-36.
7. Jančinová V, Májeková M, Nosál R, Petríková M. Inhibition of platelet functions by cationic amphiphilic drugs in relation to their physico-chemical properties. Blood Coagul Fibrinolysis 1996; 7: 191-3.
8. Nosál R, Jančinová V. Nonreceptor interactions in the pharmacology of blood platelets. Gen Physiol Biophys 1999; 18: 120-5.